FDAFDA · Food and drugs·Recall number D-0750-2021
Tizanidine HCl Tablets, USP 4 mg, 150-count bottles, Rx only, Mfd By: Dr. Reddy's Laboratories limited, Srikakulam District, 532 409 INDIA, NDC 55111-180-15.
Published August 25, 2021 · Recall initiated: July 19, 2021
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Tablet/Capsule Specification: Some tablets are shaved
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- TIZANIDINE
- Manufacturer
- Dr. Reddy's Laboratories, Inc.
- Distributor
- Nationwide within the United States
- UPC
- 0355111180104
- Lot
- Lot #: T2000471, exp date 09/2023
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.